HOME >> MEDICINE >> NEWS
Measuring proteins in spinal fluid may provide early clue to Alzheimer's disease

Chicago Early signs of the development of Alzheimer's disease can be seen in the cerebrospinal fluid of middle-aged adults who are genetically predisposed to the neurologic condition, according to a report in the July issue of Archives of Neurology, one of the JAMA/Archives journals.

The two strongest risk factors for Alzheimer's disease are aging and the presence of an allele (type of gene) known as apolipoprotein E*4 (APOE*4), according to background information in the article. Those with the APOE*4 allele develop clinical dementia about 10 to 15 years earlier than those who do not have the APOE*4 allele. Previous studies have shown that the plaques that form in the brain during Alzheimer's disease, which are made of proteins known as -amyloids, begin forming years before affected individuals experience any symptoms of the disease. As -amyloid proteins, predominately of a type known as A42, clump together, fewer are available to circulate through the nervous system. Therefore, lower levels of the A42 in the cerebrospinal fluid surrounding the brain and spinal cord serve as biomarkers or chemical indicators of the development of Alzheimer's disease.

Elaine R. Peskind, M.D., VA Puget Sound Health Care System and University of Washington School of Medicine, Seattle, and colleagues estimated the combined effect of aging and the APOE*4 allele on levels of A42 and another -amyloid, A40, in 184 adults (94 men and 90 women, average age 50 years). The participants underwent clinical and laboratory screening and were found to be cognitively normal--that is, they had no difficulties with thinking, learning or memory. Researchers took samples of cerebrospinal fluid in the morning after an overnight fast and measured participants' A42 and A40 levels in addition to determining whether each individual had the APOE*4 allele.

Those who were older and who had the APOE*4 allele were more likely to have lower levels of A42. For those who did n
'"/>

Contact: Jeri Rowe
206-764-2589
JAMA and Archives Journals
10-Jul-2006


Page: 1 2

Related medicine news :

1. Measuring lung motion leads to better radiation treatment for lung cancer
2. Measuring brain activity for emotional markers that may indicate risk for developing alcoholism
3. Measuring artery repair cells could become new heart disease test
4. Measuring certain enzyme activity in urine shows promise for detection of bladder cancer
5. Measuring hormone cuts antibiotic use in half in pneumonia patients
6. Measuring enzymes at end of cancer pathway predicts outcome of Tarceva, Taxol
7. Penn study finds pro-death proteins required to regulate healthy immune function
8. Head and neck cancer vaccine targets proteins to create immune response
9. Sticky proteins provide new insight into drug action
10. First major study of mammalian disorderly proteins
11. Keep the baby, toss the bathwater: How kidneys retain proteins, discard waste

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:11/30/2016)... ... November 30, 2016 , ... ... clinical research community that the FDA Binding Guidance goes into effect next month. ... formats listed in the FDA Data Standards Catalog. The current FDA Data Standards ...
(Date:11/30/2016)... ... November 30, 2016 , ... U.S. Security Associates (USA) ... services based in Richmond, Virginia. The acquisition further strengthens USA’s capabilities within ... security services and prides itself on 100% client-retention to the healthcare industry. In ...
(Date:11/30/2016)... Philadelphia, PA (PRWEB) , ... November 30, 2016 ... ... and pharmaceutical organizations to build intelligent, connected applications, announces today that it has ... (HITRUST). , CloudMine, has been self-certified as compliant with the HITRUST CSF ...
(Date:11/30/2016)... ... November 30, 2016 , ... Staying on top ... deductibles, more restrictive lists of healthcare providers and soaring drug costs. To help ... estimator tools, offered by New York health plans. These tools, which are ...
(Date:11/30/2016)... Linda, Ca (PRWEB) , ... November 30, 2016 , ... ... in Best in Biz Awards, the only independent business awards program judged by members ... progress as it drives revenue and growth, while maintaining partner relations. In 2015 LabRoots ...
Breaking Medicine News(10 mins):
(Date:12/2/2016)... , Dec. 2, 2016 CVS Health ... annual Analyst Day in New York City on Thursday, December 15, 2016, ... Health leadership team will provide an in-depth review of ... shareholder value. The company will also discuss 2017 earnings ... video webcast of the event will be broadcast simultaneously ...
(Date:12/2/2016)... NEW YORK , December 2, 2016 ... Extremity Braces & Support) is Expected to Gain a Significant ... Prone to Orthopedic Ailments  ... , , According ... Market Study on Medical Implants Sterile Packaging: Clamshell Product Type ...
(Date:12/2/2016)...   CytoSorbents Corporation (NASDAQ: CTSO ), ... approved CytoSorb ® cytokine adsorber to treat deadly ... that Dr. Phillip Chan , Chief Executive Officer, ... Main Event investor conference held from December 6 ... Boulevard Hotel in Los Angeles, California ...
Breaking Medicine Technology:
Cached News: